Photo: NDTV

DCGI Approves SII's Request To Manufacture Sputnik V In India

The Drug Controller General of India on June 4 approved the Serum Institute of India's request to manufacture Russian COVID-19 vaccine Sputnik-V. Adar Poonawalla-owned organisation has been granted permission to examine, test and analyse the vaccine in India. SII CEO Poonawalla thanked the Ministry of External Affairs and POTUS Joe Biden for relaxing the restrictions on vaccine manufacture. For the production, SII will join hands with… read-more

Sat, 05 Jun 2021 - 09:25 AM / by Nikita Thakur

Tags: SII, Adar Poonawalla, Sputnik-V, Russia, Covid-19, Covid Vaccine

Courtesy: Zee Business

Moscow, Russia.

Photo: TravelScapes

Travel Agency Offers 24-Day Russia Trip, Sputnik-V Jabs At Rs 1.29L

A Dubai-based travel agency has offered a 24-day trip from Delhi to Russia, where the tourists will be given two doses of Sputnik-V jab with certificate under the vaccine-tourism package. The whole trip costing Rs 1.29 lakh will also benefit the travellers with the sight-seeing around Moscow and St Petersburg. The package includes tickets, meals and 3-star hotel accommodation. However, interested travellers will have to pay Rs 10,000 as visa… read-more

Thu, 20 May 2021 - 12:56 PM / by Harsh Vardhan

Tags: Russia, Delhi, Moscow, Sputnik-V, St Peterburg, Vaccine Tourism

Courtesy: India .com

Delhi HC

Photo: The Sentinel Assam

Delhi HC Slams Centre, Asks To Prioritise Foreign Vaccine Procurement

In a plea that came up on May 18, the Delhi HC slammed the Centre for being negligent towards the collaboration and procurement of COVID-19 vaccines from foreign countries. Reportedly, the Centre is due to release funds for an Indian pharmaceutical company that collaborated with Russia's Sputnik vaccine manufacturers. HC said that the Central leaders are living in 'ivory towers' without knowing the ground reality of COVID-19 impact.

Wed, 19 May 2021 - 05:28 PM / by Vanshika Sharma

Tags: Covid Vaccination, Sputnik-V, Delhi HC, Centre

Courtesy: Times Of India

Sputnik V

Photo: Business Standard

Dr Reddy's Lab Rolls Russian Sputnik V In India At Rs 995 Per Dose

The Dr. Reddy's Laboratories on May 14 rolled out the Russian COVID-19 vaccine Sputnik V in India with the first dose administered in Hyderabad. The imported vaccine under current pilot project has been priced at Rs 995.4/dose including 5% GST. Expecting second and further imported consignments in upcoming months, DRL said supply from Indian manufacturers will commence soon. DRL also hoped of probably cheaper price when local supplies begin… read-more

Fri, 14 May 2021 - 05:54 PM / by Vanshika Sharma

Tags: Hyderabad, Russia, RDIF, Sputnik-V, Covid-19 Vaccination, Dr Reddy's

Courtesy: Times Of India

Sputnik V

Photo: USNews .com

Dr Reddy's Laboratories To Import Russia's COVID-19 Vaccine Sputnik V

Dr. Reddy's Laboratories is expected to receive 250 million doses of Russian vaccine ‘Sputnik V’ between April and June. Reportedly, the supply will be determined by considering the number of doses requested by the Centre and the cold chain mechanism in place to deliver them throughout the country. While, currently, Sputnik is negotiating with the government regarding the price, India will use the Russian Direct Investment Fund for its… read-more

Thu, 15 Apr 2021 - 11:38 AM / by Anvitha Shetty

Tags: Sputnik-V, Covid-19 Vaccine, India, Russia, RDIF

Sputnik V

Photo: Zee News

Indian Expert Committee Approves Sputnik V Vaccine For Emergency Use

The Indian subject expert committee on April 12, has approved the Russian Vaccine Sputnik V for the emergency use. This approval was made during the time of vaccine shortage in various states of the country. Partnered with Russian manufacturers, Dr. Reddy’s Laboratories will receive 100 million doses of the Sputnik V vaccine as agreed. Earlier, the expert committee sought information on Sputnik V vaccine clinical trials.

Mon, 12 Apr 2021 - 07:24 PM / by Neha Sanjeev

Tags: Russia, Covid Vaccine, Sputnik-V, Dr Reddy's

Courtesy: Deccan Herald

Covid Vaccine

Photo: DNA India

Dr Reddy's Seeks Emergency Use Approval Of Sputnik-V Vaccine

Pharmaceutical MNC Dr Reddy’s have applied for emergency use authorization of Russian COVID-19 vaccine ‘Sputnik-V’ in India. Showing 91.6% efficacy in the last-stage trials, the vaccine maker has assured to submit the test interim data by February 21. Produced by Moscow’s Gamaleya Institute and registered in almost 30 countries, the vaccine will be the most effective in India if approved. Reportedly, Reddy’s and Russian Development Investment… read-more

Fri, 19 Feb 2021 - 06:45 PM / by Nikita Thakur

Tags: Covid-19, Covid Vaccine, Dr Reddy's, Sputnik-V

Covid-19 vaccine

Photo: News Track

100Mn Sputnik V Covid Vaccines To Be Produced In India

India plans to produce over 100 million doses of Russian Covid-19 vaccine Sputnik V. As per reports, Russian Direct Investment Fund (RDIF) will help Indian pharma company Hetero in producing Sputnik V doses from early 2021. Amid ongoing lab tests of the vaccine, Dr Reddy's Laboratories expects the final trials to be over by March 2021. In addition to this, the RDIF is marketing the Sputnik V vaccine globally.

Fri, 27 Nov 2020 - 01:12 PM / by Bhavyata Kagrana

Tags: Sputnik-V, India, Russia, Covid-19, Covid-19 Vaccine, Dr. Reddy's Laboratory

Representational image

Photo: Financial Express

Interim Trial Results Of Russia's COVID Vaccine 'Sputnik V' Score 92% Efficacy

According to the interim trials, Russian COVID-19 vaccine, Sputnik V, has shown a 92% efficacy against the coronavirus. The human adenovirus vaccine uses a weakened and genetically modified virus to build an immune response. However, the mid-stage trials, which are yet to be peer-reviewed, were conducted on a small population of 16,000 participants. In India, the vaccine is being tested by Dr Reddy's Laboratories in association with the… read-more

Thu, 12 Nov 2020 - 11:27 AM / by Nitesh Kumar Singh

Tags: Russia, Covid-19 Vaccine, Sputnik-V, Coronavirus, India, Dr Reddy's, Human Trials

Courtesy: Indian Express

covid vaccine

Photo: DNA India

Dr Reddy Gets DCGI Nod; Will Start Testing World's First COVID Vaccine In India

Dr Reddy on October 17 was granted permission by the Drug Controller General of India (DCGI) to conduct phase 2 and phase 3 trials of the first registered COVID vaccine, Sputnik in India. Dr Reddy has said that the controlled study will be multi-centred and randomized and "will include safety and immunogenicity study." Earlier, DCGI had rejected Dr Reddy's proposal of human trials as Russia had tested the vaccine on a small number of people… read-more

Sat, 17 Oct 2020 - 04:29 PM / by Sneha Ramesh

Tags: India, Corona Virus Vaccine, Russia, Sputnik-V

Courtesy: Hindustan Times